MALIGNANT MIXED MULLERIAN TUMOR VERSUS HIGH-GRADE ENDOMETRIAL CARCINOMA AND AGGRESSIVE VARIANTS OF ENDOMETRIAL CARCINOMA - A COMPARATIVE-ANALYSIS OF SURVIVAL

Citation
E. George et al., MALIGNANT MIXED MULLERIAN TUMOR VERSUS HIGH-GRADE ENDOMETRIAL CARCINOMA AND AGGRESSIVE VARIANTS OF ENDOMETRIAL CARCINOMA - A COMPARATIVE-ANALYSIS OF SURVIVAL, International journal of gynecological pathology, 14(1), 1995, pp. 39-44
Citations number
24
Categorie Soggetti
Obsetric & Gynecology",Pathology
ISSN journal
02771691
Volume
14
Issue
1
Year of publication
1995
Pages
39 - 44
Database
ISI
SICI code
0277-1691(1995)14:1<39:MMMTVH>2.0.ZU;2-F
Abstract
To ascertain whether uterine malignant mixed mullerian tumors are biol ogically distinct from high-grade endometrial carcinomas (FIGO grade 3 ), we compared patient survival in 32 and 39 cases, respectively. The Cox proportional hazard model was employed to determine whether tumor type was an independent predictor of survival. The survival of patient s with MMMT was also compared to that of patients with serous adenocar cinoma and clear cell carcinoma. The 5-year overall and disease-free s urvival were significantly lower for malignant mixed mullerian tumors (25% and 11%) than for high-grade endometrial carcinomas (64% and 56%) . Using the Cox proportional hazard model, tumor type (MMMT vs. high-g rade endometrial carcinoma) was a statistically significant predictor of survival after other important prognostic variables such as patholo gic stage, depth of myometrial invasion, and vascular invasion had bee n taken into account. The increased aggressiveness of MMMT appears mos t attributable to their tendency to reach a more advanced stage by the time of clinical presentation and to their greater propensity for upp er abdominal dissemination. The survival of patients with MMMT was als o lower than that of patients with the special histologic variants of endometrial carcinoma, serous adenocarcinoma and clear cell carcinoma, which are recognized for their unusually aggressive clinical behavior . These results indicate that uterine malignant mixed mullerian tumors are clinically more aggressive than high-grade endometrial carcinomas and should continue to be recognized as a distinct entity.